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Abstract Objective: PET has the ability to evaluate functional information as well
as visualization of radiotracer uptake. Compartmental model is a basic idea to analyze
dynamic PET data. C-HED has been the most frequently used PET tracer for the
evaluation of cardiac sympathetic nervous system (SNS) function. The washout of
norepinephrine from myocardium is associated with increasing SNS activity in heart
failure (HF). However, the existence of washout of 11C-HED from the myocardium is
controversial. Although “retention index” (RI) is commonly calculated to quantify
the uptake of HED, RI is not purely able to distinguish washout parameter and uptake
parameter. Therefore, in this study, we aimed to evaluate whether HED was washed
out from the myocardium using compartment model analysis.
Material and Methods:We compared HED parameters in ten normal volunteers
(32.4 9.6 years) and nine HF patients (age: 57.3 17.3 years, LVEF:
36.1 16.7 %). Each subject underwent rest 11C-HED PET. We estimated RI,
inflow rate K1, and washout rate k2 using single-compartment model analysis
using 11C-HED PET.
Result: HF patients showed lower RI and inflow rate K1 compared to normal
volunteers (RI: 0.06 0.02 vs. 0.15 0.03 min1, p< 0.001, K1: 0.14 0.05 vs
0.20 0.03 ml/min/g, p< 0.001). Washout rate k2 also significantly increased in
HF patients (k2: 0.036 0.026 vs. 0.016 0.011 min1, p¼ 0.041).
Conclusion: HF patients showed reduced RI, reduced K1, and higher washout
rate k2 compared to normal. This result may imply that HED PET is able to
evaluate washout parameter using compartment model.
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5.1 Introduction
Positron emission tomography (PET) is a powerful tool to evaluate functional
information imaging as well as anatomical information [1, 2]. PET is the most
reliable modality for assessing functional information, especially in cardiovascular
imaging [3, 4]. When biomedical functions are analyzed using PET images, com-
partment model analysis is generally applied [5, 6]. Compartment model analysis
enables to observe the pharmacokinetics of radiotracer in human body. Thus, we
apply compartment model analysis to evaluating pharmacokinetics of 11C-
hydroxyephedrine (HED).
11C- HED has been the most frequently used PET tracer for the estimation of
cardiac sympathetic nervous system (SNS) function [7–9]. In general, 11C- HED
data has been evaluated using the retention index (RI) [8]. RI is a parameter that can
be calculated easily compared to other quantitative parameters. RI includes uptake
and washout parameters. However, RI does not differentiate washout parameters
from cardiac HED data. Cardiac washout parameter is widely used for evaluation of
SNS function and increased cardiac washout is associated with cardiac events in
heart failure (HF) [10]. Therefore, it would be important to evaluate the washout
parameters using HED PET. Compartment model analysis might have a potential to
evaluate precise pharmacokinetics of 11C-HED and also has a potential to evaluate
purely washout parameter [11].
In this study, we aimed to analyze HED uptake parameter and washout param-
eter using single-compartment model analysis in patients with HF.
5.2 Methods
5.2.1 Study Subjects
Ten healthy volunteers and nine HF patients participated in the current study. The
healthy volunteers (ten men, 32.4 9.6 years) had a low pretest likelihood of
coronary artery disease (<5 %) based on risk factors [12]. HF patients were
recruited from a group of patients who underwent HED PET for the assessment
of sympathetic neuronal function. They were six men and three women
(57.3 17.3 years). The study was approved by the Hokkaido University Graduate
School of Medicine Human Research Ethics Board. Written informed consent was
obtained from all participants.
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5.2.2 Positron Emission Tomography/Computed
Tomography 11C-HED PET/CT Imaging
11C-HED was produced from 11C-methyl iodide and metaraminol (free base) using
standard methods with high purity and high specific activity [13].
All participants were instructed to fast overnight. PET/CT imaging was
performed with a 64-slice PET/CT scanner (Biograph Siemens/CTI, Knoxville,
TN, USA). A low-dose CT was performed for attenuation correction. The CT
co-registered to standard orthogonal PET images was then re-sliced into series of
short-axis, horizontal long-axis, and vertical long-axis images.
Immediately after the administration of 5 mCi(185 MBq) of intravenous 11C-
HED, participants underwent 40-min 3D list-mode PET acquisition. The images
were reconstructed using filtered back correction with a12-mm Hann filter and were
reconstructed into 23 frames (10 10 s; 1 60 s; 5 100 s; 3 180 s;
4 300 s) [14].
5.2.3 RI Estimation
RI is obtained by normalizing late phase of tracer activity concentrations
(30–40 min) of left ventricular (LV) myocardium divided by the integral of the
arterial input function (AIF). The time-activity curve was derived from a small
circular region of interest in the left ventricular cavity (Fig. 5.1, [10]).
5.2.4 Compartment Model Analysis
Harms HJ et al. reported the single-tissue model was more robust than two-tissue
compartment model and results obtained were similar to more precise models
[11]. Thus, we used single-compartment model to evaluate 11C-HED washout
parameter.
In single-compartment model analysis, tracer kinetics are consisted by only two
parameters, which are inflow rate K1 and washout rate k2 (Fig. 5.1, [6]). In this
study, K1 and k2 were estimated using the nonlinear least squares method. This
approach used AIF arterial input function and tissue activity carve (TAC) of LV
myocardium [15, 16]. Distribution volume was also calculated [17]. The equation
of distribution volume was inflow rate K1 divided by washout rate k2.
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5.2.5 Statistical Analysis
Data are expressed as mean SD. The differences between the means of two
volumetric results were examined using the unpaired two t-test. Fisher’s exact
tests were used for categorical variables. P-value of less than 0.05 was considered
indicative of a statistically significant difference. Statistical calculations were
carried out using JMP software version 12.0 (SAS Institute, Inc., Cary, NC).
5.3 Results
5.3.1 Subjects’ Background
Table 5.1 summarizes the baseline characteristics of the volunteers and HF patients.
HF patients also had laboratory data and echocardiography data. The HF patients
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Fig. 5.1 Analysis methods of 11C-hydroxyephedrine. (a) Calculation method of retention index:
retention index was obtained by normalizing late activity concentrations of left ventricular
myocardium divided by the integral of the arterial input function.(b) Single-tissue compartment
model: single-tissue compartment model enables to monitor inflow rate K1 and washout rate k2 of
radiotracer between arterial input function (AIF) and tissue activity curve (TAC). AIF and TAC
were obtained from LV cavity and myocardial tissue, respectively
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5.3.2 HED PET Data Normal Volunteers and HF Patients
HF patients significantly decreased RI compared to normal volunteers
(0.060 0.020 vs. 0.150 0.032 1/min, P< 0.001, Fig. 5.2). In compartment
model analysis, HF patients showed decreased inflow rate K1 (0.14 0.03
vs. 0.20 0.05 ml/min/g, P¼ 0.004, Fig. 5.3a) and reduced distribution volume
(5.17 2.93 vs. 22.4 23.1 mL/g, P¼ 0.04, Fig. 5.3c). In addition, HF patients
significantly increased washout rate k2 compared to normal volunteers
(0.036 0.026 vs. 0.016 0.011 1/min, P¼ 0.044, Figs. 5.3b and 5.4.).





Age (year) 32.4 9.6 57.3 17.3 <0.001
Sex (M/F) 10/0 6/3 0.09
Height (cm) 172.7 8.8 162.2 8.4 <0.001
Wight (kg) 68.2 13.5 56.8 17.4 <0.001
Laboratory data
BNP (pg/ml) – 633.7 876.8 –
Plasma noradrenalin (pg/ml) – 469.4 317.7 –
Urinary noradrenaline
(μg/day)
– 127.9 54.5 –
Echocardiography
LVEF (%) – 36.1 16.7 –
LVEDV (ml) – 180.2 95.2 –
Data expressed as mean SD. BNP brain natriuretic peptide, LVEF left ventricular ejection









Fig. 5.2 Difference of
retention index between the
heart failure and normal.
Heart failure patients
showed significantly
decreased RI compared to
normal volunteers




























Fig. 5.3 Difference of parameters calculated using compartment model analysis. Heart failure
patients showed significantly decreased inflow rate K1 and distribution volume (a, c). Heart failure



























RI  = 0.17 (ml/min/g) 
K1 = 0.21 (ml/min/g)
k2  = 0.009 (1/min)
Distribution Volume = 24.1 (ml/g)
RI  = 0.07 (ml/min/g) 
K1 = 0.17 (ml/min/g)
k2 = 0.037 (1/min)







Fig. 5.4 Example of myocardial time activity curveswith11C-hydroxyephedrine. Heart failure
patient’s time-activity curve showed enhanced washout compared to normal volunteer’s one
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5.4 Discussion
HF patients showed decreased RI, inflow rate K1, and distribution volume com-
pared to normal volunteers. In contrast, the HF patients increased washout param-
eter k2.
Many previous studies reported patients with imparted SNS function showed
lower 11C-HED uptake [8, 17]. Thus, the present data agree with previous reports.
In this study, HF patients showed significantly increased washout rate k2
compared to normal volunteers. Previous studies using 123I-MIBG reported HF
patient showed increased washout rate [10, 18]. Previous study also reported that
washout parameter of 11C-HED was well correlated with plasma and cardiac
norepinephrine in experiments with rats [7]. Therefore, current data that HF patient
showed increased washout rate may be considered to be appropriate.
5.4.1 Study Limitation
Our study had a small population and HF patients were significantly older than
normal volunteers. Therefore, further investigations with larger and age-matched
populations are required.
In addition, washout parameters were not compared to other clinical indexes.
Comparison washout of 11C-HED and other clinical parameter such as ejection
fraction, laboratory parameter, and washout of 123I-MIBG should be the next step.
5.5 Conclusion
In this study, we applied compartment model analysis to evaluating washout of 11C-
hydroxyephedrine (HED).
As a result, HF patients showed reduced RI, K1, and distribution volume and
higher washout rate k2 compared to normal. This result may imply that HED PET is
able to evaluate washout parameter using compartment model.
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